INTERNATIONAL PATENT: JUNO THERAPEUTICS, INC. FILES APPLICATION FOR "USE OF BRIDGED CYCLE-BASED INHIBITORS OF DNA-DEPENDENT PROTEIN KINASE IN COMBINATION OF DNA POLYMERASE THETA INHIBITOR AND COMPOSITIONS AND APPLICATION IN GENE EDITING"

GENEVA, Aug. 6 -- JUNO THERAPEUTICS, INC. (400 Dexter Avenue North, Suite 1200Seattle, Washington 98109) filed a patent application (PCT/US2025/012952) for "USE OF BRIDGED CYCLE-BASED INHIBITORS OF DNA-DEPENDENT PROTEIN KINASE IN COMBINATION OF DNA POLYMERASE THETA INHIBITOR AND COMPOSITIONS AND APPLICATION IN GENE EDITING" on Jan 24, 2025. With publication no. WO/2025/160395, the details related to the patent application was published on Jul 31, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): MU, Yucheng (Route 206 and Province Line RoadPrinceton, New Jersey 08543), QIAO, Jennifer X. (Route...